Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05620134
Title	A Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	Salubris Biotherapeutics Inc
Indications	melanoma endometrial adenocarcinoma gastroesophageal adenocarcinoma follicular thyroid carcinoma colorectal adenocarcinoma transitional cell carcinoma skin squamous cell carcinoma head and neck squamous cell carcinoma papillary renal cell carcinoma triple-receptor negative breast cancer clear cell renal cell carcinoma gastric adenocarcinoma ovary epithelial cancer pancreatic adenocarcinoma cervical cancer hepatocellular carcinoma papillary thyroid carcinoma lung small cell carcinoma luminal breast carcinoma B esophagus squamous cell carcinoma lung non-small cell carcinoma
Therapies	JK08
Age Groups:	adult \| senior
Covered Countries	ESP \| BEL